• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Biochemical Assay Development Using Novel MALDI High-Throughput Screening System

4 August 2016  •  Author(s): Bruker

Whitepaper: Biochemical Assay Development Using Novel MALDI High-Throughput Screening SystemLabel-free detection methods based on mass spectrometry are gaining momentum in high-throughput screening (HTS) for pharmaceutical drug discovery.

Most of these mass spectrometry methods are centred on multiplexed LC-MS and SPE-MS. MALDI-TOF has an inherent advantage over multiplexed LC-MS and SPE-MS techniques by being 10-100 times faster. MALDI-TOF methods can also significantly reduce costs, the amount of solvent being used and the amount of chemical waste being generated.

This work focuses on developing biochemical assays where substrate and product are small molecules using a novel MALDI-HTS system.

 

The rest of this content is restricted to logged-in subscribers. Login or register (it's free!) to view the full content.

2 responses to “Biochemical Assay Development Using Novel MALDI High-Throughput Screening System”

  1. Shi Sun says:

    why can’t view more content

  2. Shi Sun says:

    I am trying to set up method for screening enzyme inhibitors

Leave a reply

 

Webinar: Different thermal analysis techniques to measure the glass transitionWATCH NOW
+ +